Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -2.19M | -3.54% | $ 61.95M |
3/31/2025 | $ -572K | -0.96% | $ 59.76M |
12/31/2024 | $ 8.67M | 16.24% | $ 53.4M |
9/30/2024 | $ 8.28M | 18.13% | $ 45.67M |
6/30/2024 | $ -2.71M | -7.13% | $ 38.05M |
3/31/2024 | $ 5.87M | 9.84% | $ 59.65M |
12/31/2023 | $ -1.32M | -2.01% | $ 65.49M |
9/30/2023 | $ -7.52M | -11.83% | $ 63.63M |
6/30/2023 | $ -9.84M | -14.59% | $ 67.46M |
3/31/2023 | $ -22.17M | -53.89% | $ 41.14M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -22.24M ] / Revenues [ $ 61.16M ]
(=) OCF % [ -36.37% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |